Emgality 300 MG (100 MG X3SYR)ML

Ended Awarded

Contract number
SPE2DB23FN13R
Awardee
Awarding agency
Obligated
$4,393

Award facts

Contract value 100% obligated
$4,393.12 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,393.12 firm fixed price delivery order is for the specialty medication Emgality 300 mg (100 mg x 3 syringes). The contract has a completion date of December 9, 2022 and was awarded on December 8, 2022.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Quick answers

Who was awarded contract SPE2DB23FN13R?

SPE2DB23FN13R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2022.

How much is contract SPE2DB23FN13R worth?

The government has obligated $4,393 on SPE2DB23FN13R.

Is contract SPE2DB23FN13R an order under another contract?

Yes. SPE2DB23FN13R is a delivery order under SPE2DB20D1109, an indefinite delivery contract.

Was contract SPE2DB23FN13R competed?

The extent of competition for SPE2DB23FN13R was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award